Prevalence of human cytomegalovirus (HCMV) GB genotypes in Thai patients

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 38, Issue 5, 2007, Pages 835-840

  Bhattarakosol, Parvapan ^a   Chantaraarphonkun, Suwimon ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 35349013485     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Amarapal P, Tantivanich S, Balachandra K. Prevalence of cytomegalovirus in Thai blood donors by monoclonal staining of blood leukocytes. Southeast Asian J Trop Med Public Health 2001; 32: 148-53.
2. Aquino VH, Figueiredo LT. High prevalence of renal transplant recipients infected with more than one cytomegalovirus glycoprotein B genotype. J Med Virol 2000; 61: 138-42.
3. Arista S, De Grazia S, Giammanco GM, Di Carlo P, lannitto E. Human cytomegalovirus glycoprotein B genotypes in immunocompetent, immunocompromised, and congenitally infected Italian populations. Arch Virol 2003; 148: 547-54.
4. Bhattarakosol P, Sithidajporn M, Bhattarakosol P. Seroprevalence of cytomegalovirus infection in Thai adults detecting by ELISA. Chula Med J 1998; 42: 935-43.
5. ed. Philadelphia: Lippincott-Raven, 1996: 2493-520.
6. Carraro E, Granato CF. Single human cytomegalovirus gB genotype shed in multiple sites at the time of diagnosis in renal transplant recipients. J Med Virol 2003; 70: 240-3.
7. Chern KC, Chandler DB, Martin DF, Kuppermann BD, Wolitz RA, Margolis TP. Glycoprotein B subtyping of cytomegalovirus (CMV) in the vitreous of patients with AIDS and CMV retinitis. J Infect Dis 1998; 178: 1149-53.
8. Chou SW, Dennison KM. Analysis of interstrain variation in cytomegalovirus glycoprotein B sequences encoding neutralization-related epitopes. J Infect Dis 1991; 163: 1229-34.
9. Coaquette A, Bourgeois A, Dirand C, Varin A, Chen W, Herbein G. Mixed cytomegalovirus glycoprotein B genotypes in immunocompromised patients. Clin Infect Dis 2004; 39: 155-61.
10. Collier AC, Handsfield HH, Ashley R, et al. Cervical but not urinary excretion of cytomegalovirus is related to sexual activity and contraceptive practices in sexually active women. J Infect Dis 1995; 171: 33-8.
11. Dworsky M, Yow M, Stagno S, Pass RF, Alford C. Cytomegalovirus infection of breast milk and transmission in infancy. Pediatrics 1983; 72: 295-9.
12. Fries BC, Chou S, Boeckh M, Torok-Storb B. Frequency distribution of cytomegalovirus envelope glycoprotein genotypes in bone marrow transplant recipients. J Infect Dis 1994; 169: 769-74.
13. Gilbert C, Handfield J, Toma E, Lalonde R, Bergeron MG, Boivin G. Human cytomegalovirus glycoprotein B genotypes in blood of AIDS patients: lack of association with either the viral DNA load in leukocytes or presence of retinitis. J Med Virol 1999; 59: 98-103.
14. Jacobson MA, Mills J. Serious cytomegalovirus disease in the acquired immunodeficiency syndrome (AIDS). Clinical findings, diagnosis, and treatment. Ann Intern Med 1988; 108: 585-94.
15. Likitnukul S, Bhattarakosol P, Poovorawan Y. Seroprevalence of cytomegalovirus infection in children born to HIV-1 infected women. Asian Pac J Allergy Immunol 2003; 21: 127-30.
16. Ljungman P, Griffiths P, Paya C. Definitions of cytomegalovirus infection and disease in transplant recipients. Clin Infect Dis 2002; 34: 1094-7.
17. Meyer-Konig U, Vogelberg C, Bongarts A, et al. Glycoprotein B genotype correlates with cell tropism in vivo of human cytomegalovirus infection. J Med Virol 1998; 55: 75-81.
18. Navarro D, Paz P, Tugizov S, Topp K, La Vail J, Pereira L. Glycoprotein B of human cytomegalovirus promotes virion penetration into cells, transmission of infection from cell to cell, and fusion of infected cells. Virology 1993; 197: 143-58.
19. Pancharoen C, Bhattarrakosol P, Thisyakorn U. Seroprevalence of cytomegalovirus infection in children. Southeast Asian J Trop Med Public Health 1998; 29: 269-2.
20. Rasmussen L, Hong C, Zipeto D, et al. Cytomegalovirus gB genotype distribution differs in human immunodeficiency virus-infected patients and immunocompromised allograft recipients. J Infect Dis 1997; 175: 179-84.
21. Rasmussen L, Nelson M, Neff M, Merigan TC, Jr. Characterization of two different human cytomegalovirus glycoproteins which are targets for virus neutralizing antibody. Virology 1988; 163: 308-18.
22. Tantivanich S, Suphadtanaphongs V, Siripanth C, et al. Prevalence of cytomegalovirus antibodies among various age groups of Thai population. Southeast Asian J Trop Med Public Health 1999; 30: 265-8.
23. Torok-Storb B, Boeckh M, Hoy C, Leisenring W, Myerson D, Gooley T. Association of specific cytomegalovirus genotypes with death from myelosuppression after marrow transplantation. Blood 1997; 90: 2097-102.
24. Urwijitaroon Y, Teawpatanataworn S, Kitjareontarm A. Prevalence of cytomegalovirus antibody in Thai-northeastern blood donors. Southeast Asian J Trop Med Public Health 1993; 24 (suppl 1): 180-2.
25. Woo PC, Lo CY, Lo SK, et al. Distinct genotypic distributions of cytomegalovirus (CMV) envelope glycoprotein in bone marrow and renal transplant recipients with CMV disease. Clin Diagn Lab Immunol 1997; 4: 515-8.